Abingworth LLP 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-11 4:54 pm Purchase |
2022-04-29 | 13D | Verona Pharma plc VRNA |
Abingworth LLP | 21,313,822 4.400% |
249,600 (+1.18%) |
Filing |
| 2020-07-31 4:05 pm Purchase |
2020-07-22 | 13D | Verona Pharma plc VRNA |
Abingworth LLP | 21,064,222 5.100% |
12,444,448 (+144.37%) |
Filing |